Laboratory of Experimental and Cell Medicine
The main goal of the laboratory is to conduct fundamental research and transfer their results to clinical use.
The tasks of the laboratory are focused on experimental and computational cardiology.
One of the main tasks that have applications to clinical cardiology is the study of cardiac tissue fibrosis and its role in the development of cardiac pathologies. Particular attention will be given to the use of viral vectors to study the consequences of inhibiting or stimulating the expression of certain genes and for translational research aimed at developing (synthetic) biomedical interventions such as cardiac gene therapy. In addition, studies will be conducted on methods for non-invasive detection of ischemia of the heart, lungs and kidneys.
Our Skills
Prognosis and criteria for the treatment of hypertrophic
cardiomyopathy
Modeling of ablation therapy in diffuse
fibrosis in the atria
Modeling and prognosis of complications in ischemic
diseases of the organ (CHD, UPS, COPD, postoperative
ischemia)
Functionality Prediction and Detection Algorithms
body in open operations and in operations for
transplants
Studying the possibility and effectiveness of cellular
therapies based on new in situ biosubstrates and the impact
paracrine effect on differentiation and substitution
damaged area
cells to treat heart and muscle damage
transdifferentiation of cells from terminal stages
for in situ scar tissue replacement
- Valeria TsvelayaHead of the Laboratory
- Konstantin AgladzeDeputy head of the laboratory
- Sheyda Frolova
- Sandaara Kovalenko
